Projects funded by the NCN
The effect of methylated resveratrol analogue 3,4,4',5-tetramethoxystilbene (DMU-212) on secretion profile and differentiation ability of human ovarian granulosa cells in 3D model
2020/37/N/NZ7/03465
Keywords:
methylated resveratrol analogues DMU-212 human ovarian granulosa cells mesenchymal cells 3D cell culture model differentiation SIRT-1
Descriptors:
- NZ7_3: Physical culture and health promotion
- NZ7_15: Toxicology
- NZ7_14: Pharmacy, pharmacotherapy, pharmacology
Panel:
NZ7 - Diagnostic tools, therapies and public health: public health, epidemiology, environmental health risks and occupational medicine, medical ethics, drug discovery and therapies, pharmacology
Host institution :
Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu, Wydział Farmaceutyczny
woj. wielkopolskie
Principal investigator (from the host institution):
Number of co-investigators in the project: 2
Call: PRELUDIUM 19 - announced on 2020-03-16
Amount awarded: 209 710 PLN
Project start date (Y-m-d): 2021-01-19
Project end date (Y-m-d): 2024-01-18
Project duration:: 36 months (the same as in the proposal)
Project status: Project completed
Project description
Download the project description in a pdf file
Note - project descriptions were prepared by the authors of the applications themselves and placed in the system in an unchanged form.